Different vaccine very soon available to people under 60, instead of AstraZeneca Vaccination with AstraZeneca will continue for people aged 60 years and older; the vaccine is still very necessary for that target group.
Vaccination with AstraZeneca continues for people aged 60 years and older As advised by the Health Council of the Netherlands, vaccination with AstraZeneca will be continued for people born in 1960 or before. People under the age of 60 will receive a different vaccine.
Fewer coronavirus infections among people who kept distancing People who follow the advice to stay 1.5 apart from others are less likely to contract the coronavirus SARS-CoV-2.
Coronavirus monitoring in sewage research expanded and extended Since March 2020, RIVM has been working with the water boards in the Netherlands to monitor sewage for traces of the coronavirus SARS-CoV-2. The measurements are an important supplement to other COVID-19 studies.
New hold on vaccination with AstraZeneca for people under 60 years The Ministry of Health, Welfare and Sport (VWS) has decided to stop vaccinating with the COVID-19 vaccine made by AstraZeneca for people under 60 (born in 1961 or later), effectively from now until Wednesday.
INHERIT Model: a tool to jointly improve health, environmental sustainability and Health Equity RIVM is involved in the Horizon2020 project INHERIT. The first article of the INHERIT project has been published, lead-authored by RIVM.
RIVM supports WHO in national capacity building for measuring foodborne disease burden RIVM’s Collaborating Centre for Risk Assessment of Pathogens in Food and Water was invited to WHO’s side event during the 41st Codex Alimentarius Commission on July 4th 2018.
Animal-free innovations in safety assessment of chemicals How can the process of validation, acceptance and use of animal-free innovative approaches to assess the safety of chemicals be facilitated?